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Von Willebrand factor (vWF) is a polymeric plasma
glycoprotein (1, 2) that promotes platelet adhesion at sites
of vascular injury (3). In plasma, vWF polymers of varying
length are assembled from 230,000-d monomers and are
maintained in the polymeric state by disulfide bonds (4).
Biologic activity, defined in vitro as the ability of vWF to
agglutinate platelets in the presence of the cationic poly-
peptide antibiotic, ristocetin, is directly related to multimer
size and to the presence of disulfide bonds (5). We assessed
the size and shape of vWF multimers by electron micros-
copy (EM) and by quasielastic light scattering (QLS)
analysis of vWF in solution. In addition, we used QLS
techniques to demonstrate the noncovalent assembly of
vWF protomers, and to derive the dissociation constant for
this process. Biologic activity was then correlated with the
size and shape parameters defined from this analysis.
FIGURE 1 Electron micrographs of vWF. An extended multimer of
native vWF is demonstrated in (a), protomers are shown in (b) and (c);
coiled multimers are depicted in (d) and (e). Specimens were metal
coated with 8 x 10-7 gm/cm2 of tungsten and photographed either in
brightfield (c) with a magnification of 169,600 x or in darkfield
(a, b, d, e) with a magnification of 128,000 x. A schematic model of the
protomer is shown in (f).
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RESULTS AND DISCUSSION
By high-resolution light and darkfield EM (Fig. 1), vWF
was found to be a flexible, linear polymer ranging in
contour length from 100 to 1,300 nm. In any given EM
field, -85% of the polymers were coiled upon themselves
with maximal diameters ranging from 60 to 200 nm and a
calculated mean radius of gyration, Rg, of 99 ± 56 nm.
Repeating protomers were discernible in the uncoiled
polymers which, themselves, were filamentous and mea-
sured 100 nm x 1.5-2.0 nm. These protomers contained a
coiled central globular region and two somewhat larger
globular heads on each end of the filamentous backbone.
Analysis of the same vWF sample by quasielastic light
scattering (QLS) revealed a similar Rg, 83 37 nm, and a
mean Stoke's radius, Rh, of 59 ± 25 nm (Table I). These
measurements and the ratio, Rg/Rh = 1.4, indicate that in
solution, as well, the average vWF polymer is not fully
extended but, rather, assumes a shape intermediate
between that of a rigid rod and an oblate ellipsoid of
revolution (Table II).
At physiologic concentrations of vWF (=20 ,ug/ml),
disulfide bond reduction with 2-mercaptoethanol reduced
average polymer size (Rg and Rh), while at higher concen-
trations (-100 ,tg/ml), no change in size was detectable by
QLS. Changes in temperature and vWF concentration
produced reversible changes in Rh, thereby permitting
calculation of the dissociation constant for protomer-
polymer assembly. The data fit best a model that assumes
the basic protomer to be a dimer of 230,000-d monomers
associating end-to-end in a noncooperative manner (6).
With these assumptions, the KD for protomer-polymer
TABLE I
VON WILLEBRAND FACTOR SIZE AND SHAPE
PARAMETERS
Method Rg(nm) Rh (nm) kg/Rh
QLS* 83 37 59 + 37 1.4
EM 99 56
*Measurements were performed at 280 in 10 mM Tris, pH 7.8, 0.15 M
NaCI using an assumed solvent viscosity (equivalent to water) of 0.8327
centipoise.
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TABLE II
DEPENDENCE OF Rg/Rh ON SHAPE
Shape RI/Rh
Sphere 0.77
Oblate Ellipsoid 0.94
Rod 1.87
assembly was 0.77 ,ug/ml at 50C, 2.4 jig/ml at 250C, and
7.7 ,Ag/ml at 370C.
Biologic activity, as measured by ristocetin-dependent
platelet agglutination using nephelometry (7), was found
to depend directly on polymer size (Fig. 2), with both Rg
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FIGURE 2 Ristocetin-dependent platelet-agglutinating activity of vWF
as a function of solution radii. Fractions of three different preparations
(closed symbols) of vWF obtained from Sephacryl S-1000 column
chromatography (Sephadex), used to purify vWF from a cryo-precipitate
of plasma and to fractionate its multimer distribution (8), were tested for
biologic activity (i.e., platelet agglutination); the same fractions were
analyzed by QLS. Activity (one unit defined as that found in 1 ml of
normal human plasma) is plotted as a function of R. (open symbols) and
of Rh (closed symbols).
and Rb varying similarly with activity. The ratio of the
slopes of these lines is one, suggesting that the overall
solution shape of vWF does not vary with changes in
multimer length.
These data show that: (a) vWF is a flexible, linear
polymer composed of repeating protomers; (b) the flexible,
coiled configuration of the polymer noted by EM exists in
solution as well; (c) disulfide bonds maintain polymer size
at physiologic concentrations, but noncovalent forces sup-
port protomer association at higher concentrations and are
possibly important for intracellular assembly; and (d) size
and shape are directly correlated with biologic activity.
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QUANTITATIVE ELECTRON MICROSCOPIC ANALYSIS OF
MICROCRYSTALLINE PROTEIN ARRAYS
A Few Precautionary Notes
DOUGLAS L. DORSET
Electron Diffraction Department, Medical Foundation o Buffalo, Inc., Buffalo, New York 14203
Electron microscopic studies of macromolecular micro-
crystals (1) have shown that, despite the 7 A-resolution
limit imposed by radiation damage for unstained materi-
als, hope remains to use the 3 A data (for example) found
in electron diffraction patterns. While initial image studies
utilize negatively stained preparations (-20 A resolution)
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